Literature DB >> 12444910

Bronchoalveolar lavage fluids of patients with lung injury activate the transcription factor nuclear factor-kappaB in an alveolar cell line.

M Nys1, G Deby-Dupont, Y Habraken, S Legrand-Poels, D Ledoux, J-L Canivet, P Damas, M Lamy.   

Abstract

In bronchoalveolar lavage (BAL) fluid from ventilated patients, cytotoxic oxidant activity is correlated with neutrophil activation. The aim of the present study was to investigate the hypothesis that BAL fluid induces activation of the transcription nuclear factor-kappaB (NF-kappaB) in human alveolar cells, in correlation with inflammatory mediators. We measured endotoxin, inflammatory cytokines [interleukin-1beta (IL-1beta), IL-8], nitrated proteins and the activity of myeloperoxidase (MPO) in BAL fluid from ventilated patients developing bronchopneumonia ( n =19 samples) or with acute respiratory distress syndrome (ARDS) ( n =14), and from ARDS/infection-free patients ( n =11). We also exposed alveolar cells to the BAL fluid or to human MPO, H(2)O(2) or HOCl, and tested nuclear extracts for the activation of NF-kappaB. IL-1beta, IL-8, nitrated protein, MPO and endotoxin levels were significantly higher in BAL fluid from patients with bronchopneumonia than in that from the ARDS and ARDS/infection-free groups. A correlation was observed between IL-8 and MPO values ( r =0.82). The level of NF-kappaB activity induced by the BAL fluid was correlated with levels of IL-1beta ( P <0.001), IL-8 ( P <0.005) and MPO ( P <0.002), and with the neutrophil count ( P <0.002), and was higher for BAL fluid from the bronchopneumonia group. NF-kappaB activation by MPO was also demonstrated. The activation of NF-kappaB by BAL fluid, especially that from bronchopneumonia patients, suggests that a similar phenomenon may occur in vivo, leading to potential amplification of the inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444910     DOI: 10.1042/cs1030577

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia.

Authors:  Lee J Quinton; Matthew R Jones; Benjamin T Simms; Mariya S Kogan; Bryanne E Robson; Shawn J Skerrett; Joseph P Mizgerd
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

2.  Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury.

Authors:  Fiona D Saunders; Martin Westphal; Perenlei Enkhbaatar; Jianpu Wang; Konrad Pazdrak; Yoshimitsu Nakano; Atsumori Hamahata; Collette C Jonkam; Matthias Lange; Rhykka L Connelly; Gabriela A Kulp; Robert A Cox; Hal K Hawkins; Frank C Schmalstieg; Eszter Horvath; Csaba Szabo; Lillian D Traber; Elbert Whorton; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-04       Impact factor: 5.464

3.  Prime-O-glucosylcimifugin attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Na Chen; Qianchao Wu; Gefu Chi; Lanan Wassy Soromou; Jinli Hou; Yanhong Deng; Haihua Feng
Journal:  Int Immunopharmacol       Date:  2013-04-24       Impact factor: 4.932

4.  The Omega-3 Fatty Acid Docosahexaenoic Acid Modulates Inflammatory Mediator Release in Human Alveolar Cells Exposed to Bronchoalveolar Lavage Fluid of ARDS Patients.

Authors:  Paolo Cotogni; Antonella Trombetta; Giuliana Muzio; Marina Maggiora; Rosa Angela Canuto
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411

5.  Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study.

Authors:  Savino Spadaro; Iryna Kozhevnikova; Paolo Casolari; Paolo Ruggeri; Tiziana Bellini; Riccardo Ragazzi; Federica Barbieri; Elisabetta Marangoni; Gaetano Caramori; Carlo Alberto Volta
Journal:  BMJ Open Respir Res       Date:  2017-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.